Abstract
Random and selective techniques to alter the mouse genome are now providing powerful tools for biomedical research. These strains provide experimental systems for understanding gene function, for studying defects in specific human genetic diseases, for preclinical testing of therapeutic agents and for developing new therapeutic interventions such as gene therapy (1,2). Even for diseases such as AIDS, which are not normally considered to be of genetic origin, these model systems are important for understanding the underlying pathophysiology of the disease process. In addition, such model systems permit studies that are inappropriate or impossible in human beings. There now exist valuable mouse models for virtually every major category of human health with new strains being generated daily. The use of these strains is rapidly spreading to scientists who have never previously used mice for investigative purposes. The Induced Mutant Resource (IMR) was established at The Jackson Laboratory (TJL), Bar Harbor, ME, in 1993 with the purpose of selecting, importing, archiving, and distributing these genetically engineered mouse strains to the scientific community (3). Adding this resource was considered to be a natural extension of ongoing activities at The Laboratory (over 2500 stocks are currently available from TJL as breeding mice, frozen embryos, or DNA samples). Even so, in 1993 there was uncertainty about the extent to which such a resource would be utilized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bedell, M. A., Jenkins, N. A., and Copeland, N. G. (1997) Mouse models of human disease. Part I: techniques and resources for genetic analysis in mice. Genes Dev. 11, 1–10.
Bedell, M. A., Largaespada, D. A., Jenkins, N. A., and Copeland, N. G. (1997) Mouse models of human disease. Part II: recent progress and future directions. Genes Dev. 11, 11–43.
Sharp, J. J. and Davisson, M. T. (1994) The Jackson Laboratory Induced Mutant Resource. Lab Anim. 23, 32–40.
Gordon, J. W., Scangos, G. A., Plotkin, D. J., et al. (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. USA 77, 7380–7384.
Smithies, O., Gregg, R. G., Boggs, S. S., et al. (1985) Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 317, 230–234.
Mansour, S. L., Thomas, K. R., and Capecchi, M. R. (1988) Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348–352.
Gu, H., Marth, J. D., Orban, P. C., et al. (1994) Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265, 103–106.
Kistner, A., Gossen, M., Zimmermann, F., et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 10,933–10,938.
Schimenti, J. and Bucan, M. (1998) Functional genomics in the mouse: phenotype-based mutagenesis screens. Genome Res. 8, 698–710.
Friedrich, G. and Soriano, P. (1993) Insertional mutagenesis by retroviruses and promoter traps in embryonic stem cells. Methods Enzymol. 225, 681–701.
Mangiarini, L., Sathasivam, K., Seller, M., et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506.
Ishibashi, S., Schwarz, M., Frykman, P. K., et al. (1996) Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J. Biol. Chem. 271, 18,017–18,023.
Mombaerts, P., Clarke, A. R., Rudnicki, M. A., et al. (1992) Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 360, 225–231.
Kuhn, R., Lohler, J., Rennick, D., et al. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263–274.
Schorle, H., Holtschke, T., Hunig, T., et al. (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621–624.
Bristol, I. J., Mähler, M., Leiter, E. H., and Sundberg, J. P. (1997) Il10 tm1Cgn, an interleukin-10 gene targeted mutation. JAX Notes 471.
Mähler, M., Serreze, D., Evan, R., et al. (1996) Il2 tm1Hor, an interleuken-2 gene targeted mutation. JAX Notes 467.
Nielsen, L. L., Gurnani, M., Catino, J. J., and Tyler, R. D. (1995) In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background, Anticancer Res. 15, 385–392.
Dietrich, W. F., Lander, E. S., Smith, J. S., et al. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75, 631–639.
Gurney, M. E., Pu, H., Chiu, A. Y., et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase. Science 264, 1772–1775.
Simpson, E. M., Linder, C. C., Sargent, E. E., et al. (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat. Genet. 16, 19–27.
Dietrich, W. F., Miller, J., Steen, R., et al. (1996) A comprehensive genetic map of the mouse. Nature 380, 149–152.
Mouse Genome Informatics (MGI) Resource, Mouse Genome Informatics (July 1998) The Jackson Laboratory, Bar Harbor, Maine. World Wide Web (URL: http://www.informatics.jax.org).
Chisari, F. V., Klopchin, K., Moriyama, T., et al. (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59, 1145–1156.
Jacks, T., Remington, L., Williams, B. O., et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1–7.
Travis, J. (1992) Scoring a technical knockout in mice. Science 256, 1392–1394.
Anderson, C. (1993) Researchers win decision on knockout mouse pricing. Science 260, 23–24.
Whittingham, D. G., Leibo, S. P., and Mazur, P. (1972) Survival of mouse embryos frozen to −196 degrees and −269 degrees C. Science 178, 411–414.
Wilmut, I. (1972) The effect of cooling rate, warming rate, cryoprotective agent and stage of development on survival of mouse embryos during freezing and thawing. Life Sci. II 11, 1071–1079.
Sztein, J. M., Farley, J. S., Young, A. F., and Mobraaten, L. E. (1997) Motility of cryopreserved mouse spermatozoa affected by temperature of collection and rate of thawing. Cryobiology 35, 46–52.
Nakagata, N. and Takeshima, T. (1993) Cryopreservation of mouse spermatozoa from inbred and F1 hybrid strains. Jikken Dobutsu 42, 317–320.
Wakayama, T., Whittingham, D. G., and Yanagimachi, R. (1998) Production of normal offspring from mouse oocytes injected with spermatozoa cryopreserved with or without cryoprotection. J. Reprod. Fertil. 112, 11–17.
Sztein, J., Sweet, H., Farley, J., and Mobraaten L. E. (1998) Cryopreservation and orthotopic transplantation of mouse ovaries: new approach in gamete banking. Biol. Reprod. 58, 1071–1074.
Avarbock, M. R., Brinster, C. J., and Brinster, R. L. (1996) Reconstitution of spermatogenesis from frozen spermatogonial stem cells. Nat. Med. 2, 693–696.
Woychik, R. P., Wassom, J. S., Kingsbury, D., and Jacobson, D. A. (1993) TBASE: a computerized database for transgenic animals and targeted mutations. Nature 363, 375–376.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Sharp, J.J., Linder, C.C., Mobraaten, L.E. (2001). Genetically Engineered Mice. In: Tymms, M.J., Kola, I. (eds) Gene Knockout Protocols. Methods in Molecular Biology, vol 158. Humana Press. https://doi.org/10.1385/1-59259-220-1:381
Download citation
DOI: https://doi.org/10.1385/1-59259-220-1:381
Publisher Name: Humana Press
Print ISBN: 978-0-89603-572-0
Online ISBN: 978-1-59259-220-3
eBook Packages: Springer Protocols